Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors

por van der Leest, Paul, Hiddinga, Birgitta, Miedema, Anneke, Aguirre Azpurua, Maria L., Rifaela, Naomi, ter Elst, Arja, Timens, Wim, Groen, Harry J. M., van Kempen, Léon C., Hiltermann, T. Jeroen N., Schuuring, Ed
Publicado 2021